CELEGHINI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 5.915
EU - Europa 2.471
AS - Asia 902
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
OC - Oceania 3
Totale 9.307
Nazione #
US - Stati Uniti d'America 5.905
PL - Polonia 716
UA - Ucraina 436
SE - Svezia 405
CN - Cina 342
IT - Italia 234
SG - Singapore 224
FI - Finlandia 152
HK - Hong Kong 149
TR - Turchia 145
GB - Regno Unito 100
IE - Irlanda 84
RU - Federazione Russa 82
BG - Bulgaria 72
CH - Svizzera 66
DE - Germania 56
FR - Francia 33
BE - Belgio 20
VN - Vietnam 10
CA - Canada 8
IN - India 6
BR - Brasile 4
CL - Cile 4
EU - Europa 4
GR - Grecia 4
ID - Indonesia 4
KR - Corea 4
PH - Filippine 4
MY - Malesia 3
NL - Olanda 3
SN - Senegal 3
AU - Australia 2
JP - Giappone 2
PK - Pakistan 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
ES - Italia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
MX - Messico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
Totale 9.307
Città #
Fairfield 838
Woodbridge 737
Warsaw 714
Ann Arbor 535
Houston 510
Chandler 415
Ashburn 405
Jacksonville 397
Wilmington 351
Seattle 333
Cambridge 273
Singapore 187
Hong Kong 149
Princeton 144
Izmir 139
Boardman 137
Beijing 86
Columbus 73
Sofia 72
Dublin 70
Bern 62
Trieste 62
Moscow 54
San Diego 45
Dearborn 43
Menlo Park 31
Helsinki 23
Des Moines 21
Milan 21
Nanjing 21
Santa Clara 18
Falls Church 16
Verona 16
Brussels 15
Ferrara 14
Chicago 13
Hefei 13
Guangzhou 12
Buffalo 11
Jinan 11
Shanghai 11
Dong Ket 10
Phoenix 10
Redwood City 10
Auburn Hills 9
Kunming 9
Norwalk 9
Nanchang 8
Sacile 7
Washington 6
Dallas 5
Hebei 5
Kocaeli 5
Los Angeles 5
Shenyang 5
Tappahannock 5
Xi'an 5
Edinburgh 4
Hangzhou 4
London 4
Zhengzhou 4
Dakar 3
Duvall 3
Fort Worth 3
Leuven 3
New York 3
Pune 3
Seoul 3
São Paulo 3
Udine 3
Wuhan 3
Wuxi 3
Anqing 2
Ansbach 2
Athens 2
Baotou 2
Berlin 2
Bremen 2
Brescia 2
Chaoyang 2
Chongqing 2
Clearwater 2
Dongguan 2
Fuzhou 2
Harbin 2
Jiaxing 2
Kediri 2
Kuala Lumpur 2
Mestre 2
Montegaldella 2
Munich 2
Nanning 2
Ottawa 2
Redmond 2
San Jose 2
San Mateo 2
Shenzhen 2
Sint-Genesius-Rode 2
Toronto 2
Xian 2
Totale 7.316
Nome #
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 344
Neuronal Dysfunction Associated with Cholesterol Deregulation. 331
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 306
Repositioning Of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice 279
In vitro evaluation of the anti-inflammatory properties of Echinacea and Ginger in normal and pathological pregnancy 268
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 230
Pre-eclampsia affects procalcitonin production in placental tissue 206
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. 170
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 164
TNF-related apoptosis inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. 158
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 156
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 153
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). 151
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 150
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis 149
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand. 145
Potential role of circulating microRNAs as early markers of preeclampsia 143
Potential pathogenetic implications of cyclooxygenase-2 overexpression in Bchronic lymphoid leukemia cells 142
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 142
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells. 141
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53(mutated) B malignant cells. 141
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-Rays absorptiometry 141
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 139
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 139
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 138
Total extract of Beta vulgaris var. cicla seeds versus its purified phenolic components: antioxidant activities and antiproliferative effects against colon cancer cells. 136
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 133
Recent advances in the therapeutic perspectives of Nutlin-3 130
PMA-induced megakaryocytic differentiation of HEL cells is accompanied by striking modifications of protein kinase C catalytic activity and isoform composition at the nuclear level. 129
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL). 129
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 128
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. 125
Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells 124
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 122
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 120
In vivo and in vitro modulatory effect of human immunodeficiency virus type-1 (HIV-1) Tat protein on protein kinase C activity. 119
Thrombopoietin enhances the aIIbb3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase. 117
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. 116
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro. 116
Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. 115
Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity 115
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 114
Selective modulation of specific protein kinase C (PKC) isoforms in primary human megakaryocytic vs. erythroid cells. 111
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 110
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia. 109
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 107
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells. 106
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. 106
Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival. 106
Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. 104
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 103
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. 103
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. 102
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 101
In vitro senescence and apoptotic cell death of human megakaryocytes. 100
HIV-1 Tat protein suppresses the nerve growth factor (NGF)-mediated differentiation of PC12 rat pheochromocytoma cell line. 99
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 99
Impaired survival of bone marrow GPIIb/IIIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. 97
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus 95
The induction of megakaryocyte differentiation is accompanied by selective Ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34+ cells. 95
Differential effects of stromal derived factor-1a (SDF-1a) on early and late stages of human megakaryocytic development. 90
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate. 89
NF-κB pathways in hematological malignancies 89
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib. 88
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 86
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients. 80
The engagement of CD4 surface antigen in the HEL haemopoietic cell line up-regulates the transforming growth factor-b1 (TGF-b1) promoter activity. 77
Subcellular localization of the regulatory HIV-1 Tat protein produced endogenously by or added exogenously to PC12 rat pheochromocytoma and human Jurkat T lymphoid cells. 73
Levels of circulating TNF‑related apoptosis‑inducing ligand in celiac disease 66
Morphological features of apoptosis in hematopoietic cells belonging to the T-lymphoid and myeloid lineages. 65
In situ polymerase chain reaction tecnique revealed by flow cytometry as a tool for gene detection. 61
Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes. 57
Totale 9.488
Categoria #
all - tutte 24.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.339 0 0 0 0 0 296 262 241 190 101 144 105
2020/20211.316 128 85 120 174 98 142 97 108 70 135 38 121
2021/2022792 37 51 32 67 31 80 44 23 97 91 74 165
2022/20231.166 94 125 84 170 118 231 1 108 172 6 44 13
2023/2024627 93 48 37 55 48 52 120 101 5 5 30 33
2024/2025509 20 29 65 183 132 80 0 0 0 0 0 0
Totale 9.488